Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies

Lupus

Volumn 9, Issue 4, 2000, Pages 299-300

  Lambert, M ^a,b   Boullier, A ^b   Hachulla, E ^a   Fruchart, J C ^b   Teissier, E ^b   Hatron, P Y ^a   Duriez, P ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Anticardiolipin antibodies; Oxidized LDL; Paraoxonase 1

Indexed keywords

ARYLDIALKYLPHOSPHATASE; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CONTROLLED STUDY; CORONARY RISK; ENZYME ACTIVITY; FEMALE; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OXIDATION; PRIORITY JOURNAL;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; ESTERASES; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED;

EID: 0034018339     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120300680198980     Document Type: Article

References (7)

1. Vaarala O, Alethan G, Jauhiainen M et al. Crossreaction between antibodies to oxidized low-density lipoprotein and to cardiolipin in systemic lupus erythematosus. Lancet 1993; 341: 923-925.
2. Hörkkö S, Miller E, Dudl E et al, Zvaifler NJ, Terkeltaub R, Pieraneli Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognitition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 1996; 98(3): 815-825.
3. Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104(1-2): 129-135.
4. Shi DM, Gu L, Xia YR et al. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 1998; 394: 284-287.
5. Boullier A, Hamon M, Walters-Laporte E et al. Detection of autoantibodies against oxidized low-density lipoproteins and IgG-bound low density lipoproteins in patients with coronary artery disease. Clin Chim Acta 1995; 238(1): 1-10.
6. Herrmann SM, Blanc H, Poirier O et al. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study. Atherosclerosis 1996; 126: 299-304.
7. Hayek T, Oiknine J, Dankner G et al. HDL apolipoprotein A-1 attenuates oxidative modification of low density lipoprotein: studies in transgenic mice. Eur J Clin Chem Biochem 1995; 33: 721-725.